Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Homology Medicines revenue
Homology Medicines's revenue is ($6.7 m undefined.
What is Homology Medicines's revenue?
- Homology Medicines's revenue growth from 2018 to 2023 is -224.97%.
- Homology Medicines has 124 employees, and the revenue per employee ratio is $-53,637.
- Homology Medicines's peak quarterly revenue was $29.3M in 2021(q1).
- Homology Medicines peak revenue was $34.0M in 2021.
- Homology Medicines annual revenue for 2022 was 3.2M, -90.56% growth from 2021.
- Homology Medicines annual revenue for 2023 was -6.7M, -307.33% growth from 2022.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Homology Medicines historical revenue
Homology Medicines's peak revenue was $34.0M in 2021. The peak quarterly revenue was $29.3M in 2021(q1).
Homology Medicines's revenue increased from $5.3m in 2018 to $-6.7M currently. That's a -224.97% change in annual revenue.
Homology Medicines annual revenue
Homology Medicines annual revenue over time
| Fiscal year / year | Homology Medicines revenue |
|---|---|
| 2018 | $5.3M |
| 2019 | $1.7M |
| 2020 | $2.7M |
| 2021 | $34.0M |
| 2022 | $3.2M |
| 2023 | ($6.7M) |
How accurately did Homology Medicines' revenue projections match actual performance?
Homology Medicines annual growth
Homology Medicines saw the greatest revenue growth in 2021, when revenue increased by 1,157.25%.
Homology Medicines had the lowest revenue growth in 2022, when revenue changed by -90.56%.
Homology Medicines annual growth rate over time
| Year | Homology Medicines growth |
|---|---|
| 2019 | -69%↓ |
| 2020 | 62%↑ |
| 2021 | 1157%↑ |
| 2022 | -91%↓ |
| 2023 | -307%↓ |
Homology Medicines quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Homology Medicines quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | $1.1M | $1.4M | $1.6M | $1.2M |
| 2019 | $270,000 | $392,000 | $441,000 | $563,000 |
| 2020 | $588,000 | $567,000 | $567,000 | $980,000 |
| 2021 | $29.3M | $2.2M | $1.7M | $802,000 |
| 2022 | $802,000 | $802,000 | $802,000 | $802,000 |
| 2023 | $2.9M | $3.2M | $1.9M | ($14.7M) |
Homology Medicines jobs nearby
Do you work at Homology Medicines?
Is Homology Medicines transparent about its revenue structure?
Homology Medicines financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 124 |
| Date Founded | 2015 |
| Headquarters | Bedford, Massachusetts |
| Number of Locations | 1 |
| Revenue | ($6.7M) |
| Net Income | -$5,005,000 |
| Tax Rate | -0.0% |
| Total Assets | $228,470,000 |
| Ticker | FIXX |
Homology Medicines jobs you might like
Homology Medicines financing
Homology Medicines received early financing of $43.5M on 2016-05-02.
| Series | Round size | Date |
|---|---|---|
| Series A | $43.5M | 05/2016 |
| Series B | $83.5M | 08/2017 |
| Post Ipo Equity | $60M | 11/2020 |
Homology Medicines investors
| Investors | Security type |
|---|---|
| 5 Am Ventures | Series A |
| Deerfield | Series A |
| ARCH Venture Partners | Series A |
| Temasek | Series A |
| ARCH Overage Fund | Series A |
| Vida Ventures LLC | Series B |
| Deerfield | Series B |
| 5 Am Ventures | Series B |
| ARCH Venture Partners | Series B |
| Fidelity Management & Research Co LLC | Series B |
| Alexandria Venture Investments | Series B |
| HBM Healthcare Investments AG | Series B |
| Novartis | Series B |
| Osage Partners | Series B |
| Vivo Capital | Series B |
| Temasek | Series B |
| Rock Springs Capital | Series B |
| Maverick Ventures | Series B |
| Pfizer Breakthrough Growth Initiative | Post Ipo Equity |
Search for jobs
Homology Medicines highest paying jobs
Zippia gives an in-depth look into the details of Homology Medicines, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Homology Medicines. The employee data is based on information from people who have self-reported their past or current employments at Homology Medicines. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Homology Medicines. The data presented on this page does not represent the view of Homology Medicines and its employees or that of Zippia.
Homology Medicines may also be known as or be related to HOMOLOGY MEDICINES, INC., Homology Medicines, Homology Medicines Inc and Homology Medicines, Inc.